Symbol Lookup

Thursday August 27, 2015 10:08 PM ET. Data delayed 15 minutes.
15.89
-0.42 (-2.58%)
Bid/Lots
15.83/1
Ask/Lots
15.89/3
Open/Prev Close
16.40/16.31
Day Range
15.66-16.40
52-Week Range
14.00-22.11
Vol/Avg Daily Vol
37.7K/69.6K
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
  • NASDAQ
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
European ADRs Advance as Mining Stocks Extend Rally
7 hours ago by MT Newswires
10:45 AM EDT, 08/27/2015 (MT Newswires) -- American depository receipts of European stocks were trading 1.3% higher at 132.42 on the Bank of New York Mellon Europe ADR Index on Thursday morning. Gainers in Continental Europe were led by oil and g...
European ADRs Trading Marginally Lower Despite Surge in National Bank of Greece Shares
11:33AM ET on Thursday Aug 06, 2015 by MT Newswires
11:33 AM EDT, 08/06/2015 (MT Newswires) -- American depository receipts of European stocks were 0.1% lower at 144.86 on the Bank of New York Mellon Europe ADR Index on Thursday after seesawing between marginal gains and losses. Decliners in Conti...
Sector Update: Health Care
8:51AM ET on Wednesday Jul 29, 2015 by Midnight Trader
08:51 AM EDT, 07/29/2015 (MT Newswires) -- Health-care shares were mainly unchanged in pre-market trade Wednesday with pharmaceutical majors Johnson & Johnson (JNJ) and Pfizer (PFE) flat. In health-care stocks news, TRACON Pharmaceuticals (TCON) ...
Sector Update: Health Care Shares Mainly Unchanged Pre-Bell
8:48AM ET on Wednesday Jul 29, 2015 by Midnight Trader
08:48 AM EDT, 07/29/2015 (MT Newswires) -- Top Health-care stocks: JNJ: flat PFE: flat ABT: flat MRK: -0.2% AMGN: +0.2% Health-care shares were mainly unchanged in pre-market trade Wednesday. In health-care stocks news, TRACON Pharmaceutica...
Analyst Actions: Trinity Biotech Price Target Cut To $20 At Roth Capital Partners, Reiterated Buy
8:17AM ET on Wednesday Jul 29, 2015 by Midnight Trader
08:17 AM EDT, 07/29/2015 (MT Newswires) -- Trinity Biotech (TRIB) saw its price target lowered to $20 from $22 by Roth Capital Partners while the firm retained its buy rating on the stock. Price: 16.57, Change: , Percent Change: ...

Company Information

Trinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. Trinity Biotech also is a provider of raw materials to the life sciences and research industries globally. Trinity Biotech markets its portfolio of almost 850 products to customers in approximately 100 countries around the world. The primary market for Trinity Biotech's diagnostic products is the Americas (which consists principally of North America and South America). Its products are classified as point-of-care, emergency medicine, clinical laboratory and blood bank screening. The Company markets products under Uni-Gold, Recombigen, Meritas, Captia, MicroTrak, Bartels, MarDx, MarBlot, Premier, Ultra2, ImmuBlot, ImmuGlo, ImmuLisa, OTOblot and EZ.

CONTACT INFORMATION

HeadquartersIDA Business Park
BRAY, Ireland 18
Phone--
Fax--

EXECUTIVE OFFICERS

Executive Chairman of the BoardRonan O'Caoimh
Chief Financial Officer, SecretaryKevin Tansley
Chief Operating Officer, Executive DirectorRory Nealon
Chief Scientific Officer, and Vice President CardiacEric Brouwer
Executive DirectorJames Walsh

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  •  
  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$386.8MBeta0.61
Revenue (TTM)$103.1MEPS$1.31
Shares Out.23.7MBook Value$8.52
Dividend Yield1.38%P/E12.5x
Annual Dividend Rate0.22 USDPrice/Sales (TTM)3.8
Ex-Div Date6/5/15P/Cash Flow (TTM)--
Pay Date7/1/15Operating Margin15.79%

*GAAP = prior to non-GAAP analyst adjusted earnings.

(Non-GAAP)*

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample